ADMA Biologics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

ADMA Biologics Stock Summary

ADMA Biologics competes with Atara Biotherapeutics, Fate Therapeutics, Sana Biotechnology, Caribou Biosciences, and Arcus Biosciences. ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey. Adma Biologics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 527 people.

ADMA Biologics Key Financial Ratios

ADMA Biologics Key Balance Sheet Accounts

ADMA Biologics Key Income Statement Accounts

ADMA Biologics Key Cash Accounts

ADMA Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining ADMA Biologics's current stock value. Our valuation model uses many indicators to compare ADMA Biologics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across ADMA Biologics competition to find correlations between indicators driving ADMA Biologics's intrinsic value. More Info.ADMA Biologics is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about  0.56  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for ADMA Biologics is roughly  1.79 . At present, ADMA Biologics' Return On Equity is projected to slightly grow based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the ADMA Biologics' earnings, one of the primary drivers of an investment's value.

ADMA Biologics' Earnings Breakdown by Geography

ADMA Biologics Systematic Risk

Today, most investors in ADMA Biologics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various ADMA Biologics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of ADMA Biologics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of ADMA Biologics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of ADMA Biologics. We use our internally-developed statistical techniques to arrive at the intrinsic value of ADMA Biologics based on widely used predictive technical indicators. In general, we focus on analyzing ADMA Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build ADMA Biologics's daily price indicators and compare them against related drivers.

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.